Target intelligence / Profile preview

Wilms Tumor 1 Protein (WT1)

Target
WT1
Molecular classification
Transcription factor, Zinc finger protein, RNA-binding protein
01

Overview

Wilms tumor 1 protein (WT1) is a zinc finger transcription factor that plays a critical role in the development of the kidneys and gonads, as well as other organs. It can function as both a tumor suppressor and an oncogene depending on cellular context. WT1 regulates gene expression and RNA metabolism, influencing cell growth, differentiation, and apoptosis. It is implicated in Wilms tumor, Denys–Drash syndrome, and acute myeloid leukemia. WT1 is also a diagnostic marker for mesothelioma and ovarian serous carcinoma. Targeting WT1 is an area of active investigation, including immunotherapeutic strategies.

Other names
WT1 proteinWilms tumor proteinWT1 transcription factor
02

Mechanism of action

Direct transcriptional repression or activation of target genes. Post-transcriptional regulation of RNA metabolism. Immunotherapy targeting WT1 expressing cells.

03

Biological functions

Organ developmentTranscriptional regulationPost-transcriptional regulationCell growthCell differentiationApoptosis
04

Disease associations

Wilms tumorDenys–Drash syndromeAcute myeloid leukemiaMesotheliomaOvarian serous carcinoma
05

Safety considerations

Off-target effects of immunotherapyContext-dependent tumor suppressor vs. oncogenic function
06

Biomarkers

Diagnosis of mesotheliomaDiagnosis of ovarian serous carcinomaMinimal residual disease monitoring in AMLRelapse detection in AML

Beyond the preview

Go deeper on Wilms Tumor 1 Protein (WT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wilms Tumor 1 Protein (WT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call